{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:00:59Z","timestamp":1792098059663,"version":"4.4.0"},"reference-count":46,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":789,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Rheum Dis"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1111\/1756-185x.12139","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T11:06:56Z","timestamp":1372936016000},"page":"568-577","source":"Crossref","is-referenced-by-count":31,"title":["Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15\u00a0years"],"prefix":"10.1111","volume":"16","author":[{"given":"Fereydoun","family":"Davatchi","sequence":"first","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hormoz","family":"Shams","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Shahram","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolhadi","family":"Nadji","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyda","family":"Chams-Davatchi","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Sadeghi Abdollahi","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Faezi","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoomeh","family":"Akhlaghi","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farimah","family":"Ashofteh","sequence":"additional","affiliation":[{"name":"Behcet's Disease Unit; Rheumatology Research Center; Shariati Hospital; Tehran University of Medical Sciences; Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,4]]},"reference":[{"key":"10.1111\/1756-185X.12139-BIB0001|apl12139-cit-0001","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archopht.1970.00990040448008","article-title":"Treatment of Behcet's disease with chlorambucil","volume":"84","author":"Mamo","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0002|apl12139-cit-0002","first-page":"314","article-title":"Behcet's disease and immunosuppressive treatment. Our personal experience","volume":"16","author":"Bietti","year":"1976","journal-title":"Mod Probl Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0003|apl12139-cit-0003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/bjo.60.1.55","article-title":"Treatment of Behcet's disease with chlorambucil","volume":"60","author":"Tricoulis","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0004|apl12139-cit-0004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archopht.1976.03910030274004","article-title":"Treatment of Behcet's disease with chlorambucil. A follow-up report","volume":"94","author":"Mamo","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0005|apl12139-cit-0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0714.1978.tb01614.x","article-title":"Ocular manifestations of Behcet's disease","volume":"7","author":"BenEzra","year":"1978","journal-title":"J Oral Pathol"},{"key":"10.1111\/1756-185X.12139-BIB0006|apl12139-cit-0006","first-page":"118","article-title":"Immunosupressive agents and Behcet's syndrome: critical analysis of results","volume":"36","author":"Benamour","year":"1978","journal-title":"Adv Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0007|apl12139-cit-0007","first-page":"455","article-title":"Immunosuppressive therapy of Behcet's syndrome. Long term follow-up evaluation","volume":"4","author":"Bonnet","year":"1981","journal-title":"J Fr Ophtalmol"},{"key":"10.1111\/1756-185X.12139-BIB0008|apl12139-cit-0008","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0161-6420(83)80014-1","article-title":"Chlorambucil in Behcet's disease. A reappraisal","volume":"90","author":"Tabara","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1111\/1756-185X.12139-BIB0009|apl12139-cit-0009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0140-6736(84)90125-9","article-title":"Chlormbucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative","volume":"8371","author":"Palmer","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.12139-BIB0010|apl12139-cit-0010","first-page":"404","article-title":"Cyclophosphamide in the treatment of the ocular manifestations of Behcet's disease","volume":"11","author":"Davatchi","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1111\/1756-185X.12139-BIB0011|apl12139-cit-0011","first-page":"20","article-title":"Prognosis in Behcet's disease","volume":"17","author":"Pivetti Pezzi","year":"1985","journal-title":"Ann Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0012|apl12139-cit-0012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Behcet's disease","volume":"70","author":"Benezra","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0013|apl12139-cit-0013","first-page":"387","volume-title":"Ophthalmology Today","author":"Davatchi","year":"1988"},{"key":"10.1111\/1756-185X.12139-BIB0014|apl12139-cit-0014","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome","volume":"20","author":"Benezra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1111\/1756-185X.12139-BIB0015|apl12139-cit-0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2008-1046132","article-title":"Cytotoxic and immunosuppressive treatment of ocular Behcet's syndrome","volume":"196","author":"Schilling","year":"1990","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1111\/1756-185X.12139-BIB0016|apl12139-cit-0016","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bjo.74.6.353","article-title":"High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behcet's disease","volume":"74","author":"Tessler","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0017|apl12139-cit-0017","first-page":"555","volume-title":"Behcet's Disease Basic and Clinical Aspects","author":"Davatchi","year":"1991"},{"key":"10.1111\/1756-185X.12139-BIB0018|apl12139-cit-0018","first-page":"569","volume-title":"Behcet's Disease, Basic and Clinical Aspects","author":"Fain","year":"1991"},{"key":"10.1111\/1756-185X.12139-BIB0019|apl12139-cit-0019","first-page":"438","article-title":"Bolus of cyclophosphamide and methylprednisolone in uveitis in Behcet's disease. Preliminary results with the use of new criteria of evaluation","volume":"143","author":"Hamza","year":"1992","journal-title":"Ann Med Interne"},{"key":"10.1111\/1756-185X.12139-BIB0020|apl12139-cit-0020","first-page":"16","volume-title":"APLAR 3rd Symposium on the Therapy of Rheumatic Diseases","author":"Davatchi","year":"1998"},{"key":"10.1111\/1756-185X.12139-BIB0021|apl12139-cit-0021","first-page":"683","volume-title":"Behcet's Disease","author":"Shahram","year":"1993"},{"key":"10.1111\/1756-185X.12139-BIB0022|apl12139-cit-0022","first-page":"692","article-title":"Pulse cyclophosphamide for ocular manifestations of Behcet's disease. Cohort study on 283 patients","volume":"65","author":"Davatchi","year":"1998","journal-title":"Rev Rheum (Engl Ed)"},{"key":"10.1111\/1756-185X.12139-BIB0023|apl12139-cit-0023","first-page":"421","volume-title":"Behcet's Disease","author":"Shahram","year":"1997"},{"key":"10.1111\/1756-185X.12139-BIB0024|apl12139-cit-0024","first-page":"898","volume-title":"Behcet's Disease","author":"Davatchi","year":"2000"},{"key":"10.1111\/1756-185X.12139-BIB0025|apl12139-cit-0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","article-title":"Treatment of Behcet's disease-an update","volume":"30","author":"Kaklamani","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/1756-185X.12139-BIB0026|apl12139-cit-0026","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1076\/ocii.9.4.219.3957","article-title":"Short-term chlorambucil for refractory uveitis in Behcet's disease","volume":"9","author":"Mudun","year":"2001","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1111\/1756-185X.12139-BIB0027|apl12139-cit-0027","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/0-306-48382-3_116","article-title":"Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behcet's disease. A preliminary report","volume":"528","author":"Shahram","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/1756-185X.12139-BIB0028|apl12139-cit-0028","first-page":"3","article-title":"Longitudinal study of chlorambucil in ocular manifestations of Behcet's disease","volume":"21","author":"Davatchi","year":"2009","journal-title":"Iranian J Ophthalmol"},{"key":"10.1111\/1756-185X.12139-BIB0029|apl12139-cit-0029","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1479-8077.2005.00139.x","article-title":"Management of ocular manifestations of Behcet's disease with cytotoxic drugs","volume":"8","author":"Davatchi","year":"2005","journal-title":"APLAR J Rheum"},{"key":"10.1111\/1756-185X.12139-BIB0030|apl12139-cit-0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1479-8077.2004.00074.x","article-title":"New and innovative therapies for Behcet's disease","volume":"7","author":"Davatchi","year":"2004","journal-title":"APLAR J Rheumatol"},{"key":"10.1111\/1756-185X.12139-BIB0031|apl12139-cit-0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1756-185X.2010.01462.x","article-title":"How to deal with Behcet's disease in daily practice","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1111\/1756-185X.12139-BIB0032|apl12139-cit-0032","unstructured":"Shahram F Davatchi F Chams H Akbarian M Chams C Tebbi ME 1990 Methotrexate in ocular Behcet disease, Preliminary report, Abstract FP-23 First APLAR Symposium on the Therapy of Rheumatic Diseases Seoul, Korea"},{"key":"10.1111\/1756-185X.12139-BIB0033|apl12139-cit-0033","first-page":"119","volume-title":"APLAR Rheumatology","author":"Shahram","year":"1992"},{"key":"10.1111\/1756-185X.12139-BIB0034|apl12139-cit-0034","first-page":"635","volume-title":"Behcet's Disease","author":"Shahram","year":"1993"},{"key":"10.1111\/1756-185X.12139-BIB0035|apl12139-cit-0035","first-page":"S217","article-title":"Outcome analysis of ocular lesions in Behcet's disease with 6 different therapeutic methods","volume":"39","author":"Davatchi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.12139-BIB0036|apl12139-cit-0036","first-page":"S356","article-title":"Methotrexate for ocular lesions of Behcet's disease. Cohort study on 262 patients","volume":"41","author":"Davatchi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.12139-BIB0037|apl12139-cit-0037","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/0-306-48382-3_118","article-title":"High dose methotrexate for ocular lesions of Behcet's disease. Preliminary short-term results","volume":"528","author":"Davatchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/1756-185X.12139-BIB0038|apl12139-cit-0038","unstructured":"Davatchi F 2000 Treatment of ocular manifestations of Behcet's Disease Beijing, China 174 6"},{"key":"10.1111\/1756-185X.12139-BIB0039|apl12139-cit-0039","first-page":"453","volume-title":"Behcet's Disease","author":"Shahram","year":"2000"},{"key":"10.1111\/1756-185X.12139-BIB0040|apl12139-cit-0040","unstructured":"Davatchi F 2002 Treatment of ocular manifestations of Behcet's Disease Thailand 28 32"},{"key":"10.1111\/1756-185X.12139-BIB0041|apl12139-cit-0041","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/0-306-48382-3_99","article-title":"Treatment of ocular manifestations of Behcet's disease","volume":"528","author":"Davatchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/1756-185X.12139-BIB0042|apl12139-cit-0042","first-page":"773","volume-title":"Behcet's Disease","author":"Shafaie","year":"1998"},{"key":"10.1111\/1756-185X.12139-BIB0043|apl12139-cit-0043","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-77174-3","volume-title":"Uveitis Scoring System","author":"Ben Ezra","year":"1991"},{"key":"10.1111\/1756-185X.12139-BIB0044|apl12139-cit-0044","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/0-306-48382-3_100","article-title":"The influence of the delay of aggressive treatment on the vision and its outcome in Behcet's disease","volume":"528","author":"Davatchi","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/1756-185X.12139-BIB0045|apl12139-cit-0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Beh\u00e7et's disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/1756-185X.12139-BIB0046|apl12139-cit-0046","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1756-185X.2010.01546.x","article-title":"Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.12139","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/1756-185X.12139\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:49:56Z","timestamp":1625496596000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.12139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,4]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1111\/1756-185x.12139","relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,4]]}}}